Phase II study of the oral MEK inhibitor selumetinib (AZD6244) in advanced acute myeloid leukemia (AML).


Conference Paper

Full Text

Duke Authors

Cited Authors

  • Jain, N; Curran, E; Iyengar, NM; Diaz-Flores, E; Kunnavakkam, R; Popplewell, L; Kirschbaum, MH; Erba, HP; Green, M; Poire, X; Koval, G; Shannon, K; Atallah, EL; Dy, P; Smith, SE; Doyle, LA; Larson, RA; Stock, W; Odenike, O

Published Date

  • May 20, 2012

Published In

Volume / Issue

  • 30 / 15

Published By


  • 1

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

International Standard Serial Number (ISSN)

  • 0732-183X

Conference Name

  • 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)

Conference Location

  • Chicago, IL

Conference Start Date

  • June 1, 2012

Conference End Date

  • June 6, 2012